EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Identification of PRKCB, NLRC4, and TNFSF10 as Key Regulators of the Lipid Metabolism‐Autophagy Network in Atherosclerosis

Min Li, Yanjun Sun, Yanyi Sun, Zhenyue Chen

Cell Biochemistry and Function · 2026-07 · 44 (7)

DOI: 10.1002/cbf.70221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, online erschienen am 02.07.2026. Verfasst von Min Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China. Hauptthemen laut MEDLINE: Lipid Metabolism, Atherosclerosis, Protein Kinase C beta, Calcium-Binding Proteins. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Chinese Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The occurrence and development of atherosclerosis (AS) are closely related to disorders of lipid metabolism and dysfunction of autophagy. However, the key regulatory genes and immune microenvironment characteristics require further exploration.

Methods

This study integrated the bulk transcriptome and single‐cell RNA sequencing data, and utilized bioinformatics methods to screen the differentially expressed genes (DEGs) of AS. The weighted gene co‐expression network analysis (WGCNA) was used to identify the key gene modules related to lipid metabolism and autophagy. The core regulatory genes were further screened based on the machine learning algorithm (LASSO regression). The enrichment scores of 28 immune cell subtypes were calculated by ssGSEA, and the correlation between the immune infiltration characteristics and the expression levels of the three core genes (PRKCB, NLRC4, and TNFSF10) was analyzed by Spearman correlation analysis. The single‐cell transcriptome data analysis was performed to determine the cell subtype distribution characteristics of the core genes and to compare the expression differences in lipid metabolism‐autophagy‐related gene expression across distinct cell subtypes. In addition, we screened potential drugs targeting the key genes from the public drug database, and simulated the binding mode of approved drugs with the active site of PRKCB by molecular docking technology. Ultimately, the expression of target factors in mouse aortic tissues was determined by quantitative real‐time PCR (RT‐qPCR), Western blotting, and immunohistochemical (IHC) analysis. Concurrently, the levels of TNFSF10 in mouse plasma were confirmed through enzyme‐linked immunosorbent assay (ELISA).

Result

Three lipid metabolism‐autophagy core regulatory genes, PRKCB, NLRC4, and TNFSF10, were identified. These genes were significantly associated with the immune microenvironment of AS plaques and exhibited different cell subpopulation distribution patterns. The macrophage subpopulations showed higher lipid metabolism‐autophagy regulatory activity. Molecular docking revealed that the anti‐atherosclerotic drugs quercetin and atenolol can stably bind to the active site of PRKCB (with docking energies of ‐8.3 kcal/mol and ‐6.2 kcal/mol, respectively), a finding that identifies PRKCB as a candidate target worthy of further attention. Experimental evidence confirmed that the expression of these three key factors was significantly elevated in atherosclerotic plaque tissue, and the levels of TNFSF10 in the plasma of atherosclerotic mice were also significantly higher than those in the control group.

Conclusion

This study identifies PRKCB, NLRC4, and TNFSF10 as key hub genes that link lipid metabolism and autophagy in AS, and highlights their potential as diagnostic biomarkers and therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipid MetabolismAtherosclerosisProtein Kinase C betaCalcium-Binding ProteinsCARD Signaling Adaptor ProteinsAnimalsMiceMolecular Docking SimulationHumansMice, Inbred C57BL

Substanzen

Protein Kinase C betaCalcium-Binding ProteinsCARD Signaling Adaptor Proteins

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.
  • Department of Cardiovascular Surgery, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Chinese Postdoctoral Science Foundation
  • Chinese Pharmaceutical Health and Development Foundation
  • Chinese Cardiovascular Association-Natural lipid-lowering drugs fund

Zitieren

APA

Li, M., Sun, Y., Sun, Y., & Chen, Z. (2026). Identification of PRKCB, NLRC4, and TNFSF10 as Key Regulators of the Lipid Metabolism‐Autophagy Network in Atherosclerosis. Cell Biochemistry and Function, 44(7). https://doi.org/10.1002/cbf.70221

Vancouver

Li M, Sun Y, Sun Y, Chen Z. Identification of PRKCB, NLRC4, and TNFSF10 as Key Regulators of the Lipid Metabolism‐Autophagy Network in Atherosclerosis. Cell Biochemistry and Function. 2026;44(7). doi:10.1002/cbf.70221

BibTeX
@article{Li2026,
  author = {Li, Min and Sun, Yanjun and Sun, Yanyi and Chen, Zhenyue},
  title = {Identification of PRKCB, NLRC4, and TNFSF10 as Key Regulators of the Lipid Metabolism‐Autophagy Network in Atherosclerosis},
  journal = {Cell Biochemistry and Function},
  year = {2026},
  volume = {44},
  number = {7},
  doi = {10.1002/cbf.70221}
}
Kostenlos starten →